<DOC>
	<DOCNO>NCT00003182</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I/II trial study effectiveness cisplatin gemcitabine treat patient advance squamous cell cancer head neck surgically remove .</brief_summary>
	<brief_title>Cisplatin Gemcitabine Treating Patients With Advanced Squamous Cell Cancer Head Neck</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose dose limit toxicity gemcitabine use combination cisplatin treatment squamous cell carcinoma head neck . II . Determine toxicity profile combination treatment patient . III . Assess response rate treatment patient . OUTLINE : This dose escalation study gemcitabine . Patients receive gemcitabine IV bolus day 1 every 2 week . Cisplatin administer day 1 every 2 week . In absence dose limit toxicity ( DLT ) first 3 patient treat , subsequent cohort 3 patient receive escalate dos gemcitabine schedule . If 1 3 patient cohort experience DLT , additional 3 patient enrol dose level . If 2 3 patient experience DLT cohort , dose escalation cease next low dose declare maximum tolerated dose . Patients assessed response every 2 week . Patients may continue treatment 9 month disease progression . PROJECTED ACCRUAL : At least 3 patient accrued phase I 20-40 patient accrue phase II study .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage III IV squamous cell carcinoma head neck surgically unresectable curable radiation therapy Upper aerodigestive tract Unresectable recurrent disease follow initial therapy surgery and/or radiation Measurable evaluable disease PATIENT CHARACTERISTICS : Age : Over 18 Performance status : SWOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 3 time institutional normal Transaminases great 3 time institutional normal Renal : Creatinine clearance great 40 mL/min Cardiovascular : Adequate cardiac function No heart failure Pulmonary : Adequate pulmonary function require supplemental oxygen Other : Not pregnant Fertile patient must use adequate contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Prior radiation therapy allow Surgery : Prior surgery allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2000</verification_date>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>recurrent nasopharyngeal cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>recurrent lip oral cavity cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>recurrent hypopharyngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage IV laryngeal cancer</keyword>
	<keyword>recurrent laryngeal cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage IV paranasal sinus nasal cavity cancer</keyword>
	<keyword>recurrent paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>recurrent oropharyngeal cancer</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>